Toronto Woman Sues Insurer for Disability Benefits Amid Alzheimer’s Diagnosis

A woman from Toronto is taking legal action against her insurer, Sun Life, after being denied disability benefits linked to her early-onset Alzheimer’s disease. Kara Goldsmith, a former lawyer for one of Canada’s largest communications companies, began experiencing cognitive decline during the pandemic. Despite her struggles, she continued working until losing her job in 2021, which the company attributed to restructuring.

It was only after her departure that Goldsmith received a formal diagnosis of Alzheimer’s disease. Following this diagnosis, she filed a claim for long-term disability benefits, but Sun Life denied her request, stating that her disability did not commence until after her insurance coverage ended. The company asserted that there was “no continuous illness-related absence” prior to the end of her policy.

Goldsmith is now suing Sun Life for breaching the insurance contract. In her statement, she claims the insurer acted in bad faith and denied her claim based on “unreasonable and superficial reasons.” She seeks $500,000 or a declaration that she was disabled while insured, which would entitle her to retroactive benefits.

Legal and Medical Perspectives on the Case

Sun Life has countered Goldsmith’s allegations, asserting that to qualify for long-term disability benefits, she must demonstrate that she was “totally disabled” while covered by the policy. The company contends that Goldsmith’s claim was filed late and that the medical evidence provided did not substantiate her claim of being unable to perform her job duties before her termination.

According to the Alzheimer Society of Canada, while most insurance companies provide coverage for Alzheimer’s and other forms of dementia, they typically require a formal diagnosis. This requirement can lead to complications, as obtaining a diagnosis often takes years due to limited access to healthcare professionals. A report by the Brainwell Institute in July highlighted systemic issues in the Canadian healthcare system, noting that only 41 percent of family doctors feel prepared to diagnose dementia-related conditions. The average wait time from symptom onset to diagnosis is estimated at 21 to 28 months.

Goldsmith’s husband, Charles, emphasized the challenges faced by individuals with progressive conditions like dementia, which often complicate employment and insurance matters. He expressed concern for others in similar situations who may not have the support they need, stating, “What about other Alzheimer’s patients who have no such backup through their family, friends… Where do they go?”

Challenges in the System

Aman Chaggar, a Toronto-based lawyer specializing in disability insurance claims, noted the struggles faced by individuals with complex mental health conditions. He stated, “There’s a significant difference in the bargaining power between the two parties. You have somebody who’s a vulnerable person, who’s trying to figure out what’s going on with them.” This imbalance can lead to many individuals opting out of pursuing their claims, feeling overwhelmed by the process.

Goldsmith’s case has brought attention to the broader issue of how the insurance system addresses dementia and cognitive decline. Sian Lockwood from the Alzheimer Society of Canada highlighted that delays in diagnosis can leave individuals particularly vulnerable in insurance frameworks that do not account for cognitive decline.

Goldsmith’s family believes that her story illustrates the inadequacies of the current system, which often fails to support those with complex health conditions. As they navigate the legal process, they hope to shed light on the challenges faced by many Canadians with Alzheimer’s and similar diseases.